GlycoMimetics announces results from Phase 3 study of uproleselan in RR AML
PremiumThe FlyGlycoMimetics announces results from Phase 3 study of uproleselan in RR AML
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
GlycoMimetics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyGlycoMimetics downgraded to Neutral from Buy at H.C. Wainwright
3M ago
GlycoMimetics’ uproleselan does not meet Phase 3 endpoint in AML
PremiumThe Fly
GlycoMimetics’ uproleselan does not meet Phase 3 endpoint in AML
3M ago
GlycoMimetics reports cash and cash equivalents of $31.3M as of March 31
PremiumThe Fly
GlycoMimetics reports cash and cash equivalents of $31.3M as of March 31
3M ago
GlycoMimetics Provides Update with Investor Presentation
PremiumCompany AnnouncementsGlycoMimetics Provides Update with Investor Presentation
5M ago
GlycoMimetics Inc (GLYC) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
GlycoMimetics Inc (GLYC) Q4 Earnings Cheat Sheet
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100